Ken Moseley - Net Worth and Insider Trading
Ken Moseley Net Worth
The estimated net worth of Ken Moseley is at least $8 dollars as of 2024-11-13. Ken Moseley is the Sr. VP and General Counsel of Bellicum Pharmaceuticals Inc and owns about 113 shares of Bellicum Pharmaceuticals Inc (BLCM) stock worth over $8. Details can be seen in Ken Moseley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ken Moseley has not made any transactions after 2017-07-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ken Moseley
Ken Moseley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ken Moseley owns 2 companies in total, including Marker Therapeutics Inc (MRKR) , and Bellicum Pharmaceuticals Inc (BLCM) .
Click here to see the complete history of Ken Moseley’s form 4 insider trades.
Insider Ownership Summary of Ken Moseley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MRKR | Marker Therapeutics Inc | 2018-12-21 | General Counsel |
| BLCM | Bellicum Pharmaceuticals Inc | 2017-07-13 | Vice President |
Ken Moseley Latest Holdings Summary
Ken Moseley currently owns a total of 1 stock. Ken Moseley owns 113 shares of Bellicum Pharmaceuticals Inc (BLCM) as of July 13, 2017, with a value of $8.
Latest Holdings of Ken Moseley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BLCM | Bellicum Pharmaceuticals Inc | 2017-07-13 | 113 | 0.07 | 8 |
Holding Weightings of Ken Moseley
Ken Moseley Form 4 Trading Tracker
According to the SEC Form 4 filings, Ken Moseley has made a total of 0 transactions in Bellicum Pharmaceuticals Inc (BLCM) over the past 5 years. The most-recent trade in Bellicum Pharmaceuticals Inc is the sale of 1,382 shares on July 13, 2017, which brought Ken Moseley around $169,470.
Insider Trading History of Ken Moseley
- 1
Ken Moseley Trading Performance
Ken Moseley Ownership Network
Ownership Network List of Ken Moseley
Ownership Network Relation of Ken Moseley
Ken Moseley Owned Company Details
What does Marker Therapeutics Inc do?
Who are the key executives at Marker Therapeutics Inc?
Ken Moseley is the General Counsel of Marker Therapeutics Inc. Other key executives at Marker Therapeutics Inc include Interim CFO Eliot M Lurier , 10 percent owner Mohamad Makhzoumi , and 10 percent owner Carmen Chang .
Marker Therapeutics Inc (MRKR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Marker Therapeutics Inc (MRKR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Marker Therapeutics Inc (MRKR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Marker Therapeutics Inc (MRKR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Marker Therapeutics Inc Insider Transactions
Ken Moseley Mailing Address
Above is the net worth, insider trading, and ownership report for Ken Moseley. You might contact Ken Moseley via mailing address: C/o Bellicum Pharmaceuticals, Inc., 2130 W. Holcombe Blvd., Ste. 800, Houston Tx 77030.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
